Language Select
Varian Logo


Recent News
Oct 17, 2017

Varian (NYSE: VAR) today announced an 80-year-old male with head & neck cancer became the first patient in Europe to be treated on the Halcyon™ system at University Hospitals Leuven (UZ Leuven)...

Oct 2, 2017

Varian (NYSE: VAR), global leader in radiotherapy treatments systems and software, is announcing the publication of its annual Sustainability Report, detailing the company's policies and...

Sep 21, 2017

Crawley, U.K. — September 21st, 2017 — Cancer patients in the U.K. will gain access to the country’s first Varian Halcyon™ radiotherapy treatment devices when the first of two systems are...

More news >

Recent Blog Posts
Aug 30, 2017Centerline
Filippo Alongi, MD, director of radiation oncology at Sacro Cuore Don Calabria Cancer Care Center (Negrar-Verona, Italy), recently became the first clinician to use HyperArc™ high-definition radiosurgery in the treatment of brain lesions and metastases.
Read more
Aug 17, 2017Centerline
Multidisciplinary tumor boards are important for the continuity of care and improved patient outcomes. Maximizing the effectiveness of tumor boards is one reason Cone Health is implementing the Multidisciplinary Tumor Board module of the Varian 360 Oncology™ care management platform.
Read more
Aug 16, 2017Centerline
Varian’s RapidPlan™ knowledge-based planning is helping clinicians at centers around the world take treatment planning to new levels of consistency, efficiency, and quality.
Read more
Corporate Communications Contacts
Mark Plungy
Director, Public Relations
Mike Bruff
VP, Investor Relations
1 650 424 5163
Neil Madle
Director, Corporate Communications/Investor Relations, Europe
+44 (0)7786 526 068
  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.

Varian Logo